The phenomenon of cancer overdiagnosis, the diagnosis of a malignant tumour that, without detection, would never lead to ...

3 Clinical Epidemiology Research and ... than men (37.7%), whereas the age-standardised prevalence of erosive and symptomatic OA was much higher in women (9.9% vs 3.3%, and 15.9% vs 8.2%). The crude ...

Specifically, we aimed to identify the detected incidence of autoimmune myasthenia and the detected prevalence of genetically confirmed congenital myasthenic syndrome (CMS) in children. Methods All ...

Background: The prevalence of childhood asthma in the USA increased by 50% from 1980 to 2000, with especially high prevalence in poor urban communities. Methods: Data on the prevalence of asthma among ...

a focused literature review was conducted on the epidemiology of PAD. The PAD results were grouped into symptoms, diagnosis, prevalence, and incidence both in the United States and globally, risk ...

diabetes & endocrinology epidemiology general diabetes public health http ... Epidemiological data on the prevalence and incidence of type 1 diabetes in Ireland are limited, and this study provides ...

Moreover, people with dementia rarely have dementia alone, Lusk stated in an opinion article. "The presence of other severe ...

New cases of dementia in the United States declined from 2015 to 2021, but the number of people living with the condition ...

Incidence and prevalence of atrial fibrillation (AF) are expected to increase dramatically; however, we currently lack comprehensive data on temporal trends in unselected clinical populations. The ...

Objective: To examine the epidemiology, primary care burden and treatment ... 11 CMR allows accurate estimation of the prevalence, incidence and consultation rates for AF in primary care and ...

Objective To examine temporal trends in incidence of Rolandic epilepsy (RE), prevalence of comorbidities and antiepileptic drug (AED) prescribing patterns. Design Retrospective cohort study. Setting ...

knu.ac.kr Main results: Compared with children with non-detectable levels of POPs, adjusted prevalence ORs (95% CIs) of LD among those with detectable levels of HPCDD, OCDD or HPCDF were 2.08 ( 1.17 ...